IRIS
CLERICO, ALDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.150
EU - Europa 31.905
AS - Asia 8.552
SA - Sud America 1.493
Continente sconosciuto - Info sul continente non disponibili 202
AF - Africa 100
OC - Oceania 18
Totale 79.420
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 36.251
GB - Regno Unito 14.299
RU - Federazione Russa 5.890
UA - Ucraina 3.941
SG - Singapore 2.835
DE - Germania 2.326
CN - Cina 2.255
IT - Italia 2.019
HK - Hong Kong 1.524
VN - Vietnam 1.462
BR - Brasile 1.369
SE - Svezia 850
CA - Canada 832
DK - Danimarca 782
FI - Finlandia 654
PL - Polonia 546
FR - Francia 228
EU - Europa 202
IE - Irlanda 199
IN - India 67
ID - Indonesia 62
BD - Bangladesh 53
KR - Corea 50
TR - Turchia 49
NL - Olanda 44
AR - Argentina 42
ZA - Sudafrica 39
IQ - Iraq 37
MX - Messico 35
RO - Romania 28
EC - Ecuador 23
PK - Pakistan 22
UZ - Uzbekistan 21
JP - Giappone 20
MA - Marocco 19
LT - Lituania 16
AT - Austria 14
SK - Slovacchia (Repubblica Slovacca) 14
AU - Australia 13
ES - Italia 13
VE - Venezuela 13
IL - Israele 12
TN - Tunisia 12
CO - Colombia 11
IR - Iran 10
JO - Giordania 10
PY - Paraguay 10
KE - Kenya 8
BE - Belgio 7
CL - Cile 7
PE - Perù 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
DZ - Algeria 6
CH - Svizzera 5
DO - Repubblica Dominicana 5
EG - Egitto 5
KZ - Kazakistan 5
NP - Nepal 5
NZ - Nuova Zelanda 5
OM - Oman 5
RS - Serbia 5
SA - Arabia Saudita 5
AO - Angola 4
HR - Croazia 4
JM - Giamaica 4
LB - Libano 4
NI - Nicaragua 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AL - Albania 3
AM - Armenia 3
BH - Bahrain 3
BO - Bolivia 3
HN - Honduras 3
MY - Malesia 3
NG - Nigeria 3
PA - Panama 3
PS - Palestinian Territory 3
SM - San Marino 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
GT - Guatemala 2
KH - Cambogia 2
KW - Kuwait 2
LU - Lussemburgo 2
PR - Porto Rico 2
SN - Senegal 2
SV - El Salvador 2
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EE - Estonia 1
KG - Kirghizistan 1
LK - Sri Lanka 1
Totale 79.414
Salva come PNG Salva come JPEG
Città #
Southend 12.638
Woodbridge 5.121
Ann Arbor 4.000
Chandler 3.260
Houston 2.986
San Mateo 2.512
Dearborn 1.956
Jacksonville 1.917
Beijing 1.719
Falls Church 1.474
Hong Kong 1.446
Singapore 1.314
Fairfield 1.187
Seattle 1.043
Cambridge 947
Wilmington 833
Moscow 831
Dong Ket 828
Stevenage 761
Portsmouth 693
Boardman 658
Lawrence 610
Ashburn 602
Warsaw 537
Pisa 466
Ottawa 457
Brooklyn 451
Chicago 340
The Dalles 203
Montréal 195
Los Angeles 192
Dublin 185
Old Bridge 185
Santa Clara 175
Salt Lake City 163
San Diego 136
Buffalo 111
Beauharnois 107
São Paulo 102
Redwood City 101
Norwalk 95
Tampa 81
Elk Grove Village 63
London 62
Milan 61
Munich 55
Rome 52
Rio de Janeiro 51
New York 48
Belo Horizonte 47
Dallas 41
Fremont 37
Lancaster 32
Seoul 32
Washington 32
Augusta 31
Kansas City 31
Brasília 30
Central District 30
Sterling 30
San Francisco 29
Simi Valley 29
Hefei 27
Salerno 27
Florence 26
Curitiba 25
Helsinki 25
Mountain View 24
Bologna 23
Dulles 23
Johannesburg 22
Phoenix 22
Porto Alegre 22
Boston 21
Nanjing 21
Montreal 20
Timisoara 20
Frankfurt am Main 19
Kunming 19
Tashkent 19
Detroit 18
Napoli 18
Nuremberg 18
Pavia 18
Miami 17
Baghdad 16
Dhaka 16
Hanover 16
Jinan 16
Tokyo 15
Trieste 15
Turku 15
Atlanta 14
Bratislava 14
Foggia 13
Guangzhou 13
Islington 13
Istanbul 13
Salvador 13
Shanghai 13
Totale 55.150
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.483
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 606
siRNA-mediated targeting of endothelial VWF prevents ET-1 upregulation in porcine aortic endothelial cells chronically exposed to angiotensin II 288
Downregulation of von Willebrand Factor prevents Ang II-induced endothelin-1 expression independently of eNOS activation in porcine endothelial cells 282
Gene silencing of endothelial von Willebrand Factor attenuates angiotensin II-induced endothelin-1 expression in porcine aortic endothelial cells. 274
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 244
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 239
State of the art of BNP and NT-proBNP immunoassays: The CardioOrmoCheck study 224
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 222
Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system. 211
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 207
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 205
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 201
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 199
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin i 199
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 197
Direct comparison of B-Type Natriuretic Peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data 192
B-type natriuretic peptide secretion following scuba diving 191
Proposta per l’utilizzo in Pronto Soccorso delle troponine cardiache misurate con metodi di ultima generazione in pazienti con sospetto di sindrome coronarica acuta senza sopraslivellamento del tratto ST 190
Marcatori di rimodellamento e fibrosi cardiaca 187
Prognostic value of combined use of B-ype natriuretic peptides and interleukine-6 in predicting cardiac mortalità in end-stage renal disease patients 182
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 181
125I-Endothelin-1 binding sites in human cardiac tissue 180
Natriuretic peptides (NPs): Automated electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals. 180
Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay of the N-terminal fragment of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. 179
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 179
Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure 179
Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients with Stable Angina 179
Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance 178
Valutazione esterna di qualità dei peptidi natriuretici BNP e NT-proBNP: risultati del programma Cardioormocheck 178
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 178
Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure. 177
Methodological assessment of mitochondrial respiratory chain-enzyme activities in cardiac tissue 177
Distribution of plasma cardiac troponin-I values in healthy subjects: pathophysiological considerations 176
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 176
Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples 176
No variation in Hsp70 mRNA level during cardiac surgery in pediatric patients evaluated by semiquantitative RT-PCR 175
S-nitrosoglutathione as a substrate of gamma-glutamyltransferase (GGT)- A kinetic study 173
A sensitive and accurate plasma noradrenaline assay using a modified fluorimetric method. 172
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 172
Analytical performance and clinical results of a fully automated MEIA system for brain natriuretic peptide assay: comparison with a point of care testing method 172
The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex 169
N-terminal proB-type natriuretic peptide (NT-proBNP) is superior to BNP for the detection of eraly/mild forms of heart failure 169
A chromatographic method for the determination of uric acid turnover in man 168
The combined use of neutrophil gelatinase-associated lipocalin and brain natriuretic peptide improves risk stratification in pediatric cardiac surgery 168
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC). 168
Rilevanza clinica e interpretazione dei marcatori biochimici nello scompenso cardiaco 168
Stato dell’arte dell’immunodosaggio dei peptidi natriuretici di tipo B 168
Comparison of the diagnostic accuracy of BNP and NT-proBNP in acute and chronic heart failure. Reply Letter 167
New and emerging biomarkers of heart failure 167
N-terminal fragment of brain natriuretic peptide predicts vascular health and subclinical atherosclerosis: results from MEHLP study 167
Deoxyribonucleic acid damage in human lymphocytes after percutaneous transluminal coronary angioplasty 165
A chemiluminescence immunoassay for CA 15-3, CA 125, CA 19-9: evaluation using quality control sera assayed in an interlaboratory survey 165
BNP values in the first days of life measured with an automated immunoassay platform 165
A new immunoradiometric assay for the measurement of N-terminal fragment of proatrial natriuretic peptide in human plasma: relationship with atrial and brain natriuretic peptides 165
Prognostic complexity of heart failure and network analysis: the holistic risk stratification 163
Genomic medicine and thrombotic risk: who, when, how and why? 163
Gamma-glumamyl-transferase levels are associated with inflammatory activation, myocardial dysfunction and mortality in pateints with ST-elevation myocardial infarction 163
Natriuretic peptide testing in primary care patients. 162
Plasma gamma-glutamyltransferase fractions: diagnostic and prognostic predictive value 162
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible? 162
Risk factors and prognostic value of daytime Cheyne-Stokes respiration in chronic heart failure patients 161
New biomarkers for risk stratifications in patients with heart failure: high-sensitivity troponin I and galectin-3 161
Comparison of the Diagnostic Accuracy of Brain Natriuretic Peptide (BNP) and the N-Terminal Part of the Propeptide of BNP Immunoassays in Chronic and Acute Heart Failure: A Systematic Review 160
Evaluation of analytical performance and qualità specifications of a novel immunoenzymometric assay for cTnI: comparison with cTnI and cTnT immunoassays 160
Heat shock protein 70-1 gene expression in pediatric heart surgery using blood cardioplegia. 159
Abnormal circulating levels of muscle enzymes and myoglobin in hypothyroidism: their significance and usefulness in follow-up of replacement therapy of the metabolic disorder 159
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 159
Neuro-hormonal activation predicts ventilatory response to exercise and functional capacity in patients with heart failure. 158
Ultrafiltration: a rational treatment for heart failure. 157
Plasma levels of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and N-terminal fragment of pro-ANP in heart failure and in controls 157
Predictive Value of NT-proBNP in Patients with Acute Myocardial Infarction 157
Clinical relevance of time course of BNP levels in neonates with congenital heart diseases 156
Comparison of two BNP immunoassays using the same antibodies and standard materials 155
Reference values for urinary neutrophil gelatinase-associated lipocalin (NGAL) in pediatric age measured with a fully automated chemiluminescent platform 155
Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences 155
Immunoradiometric assay of serum myosin as a marker of myocardial cell damage: methodological and clinical evaluation 154
Cardiac Natriuretic Hormones, Neuro-Hormones, Thyroid Hormones and Cytokines in Normal Subjects and Patients with Heart Failure. 153
C-type natriuretic peptide expression in patients with chronic heart failure: effects of aerobic training. 153
Diagnosis of preclinical /mild heart failure with B-type natriuretic peptides: compariosn betwwen BNP and NT-proBNP immunoassay methods 153
Determinazione dei siti di legame dell’endotelina su membrane di atrio e di ventricolo bovino: un modello per studi di legame du tessuto cardioaco umano 153
Diagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart diseases 152
Methodological and clinical evaluation of the Liaison automated analyser for the qunatitative detrmination of 25-OH-vitamin D. 152
Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia 152
Circulating levels of cardiac natriuretic peptides measured by highly sensitive and specific IRMA methods in normal subjects and in patients with heart failure 152
Gamma-glutamyltransferase levels are associated with inflammatory activation, myocardial dysfunction and in-hospital mortality in patients with ST-elevation myocardial infarction 152
The non-thyroidal illness syndrome after coronary artery bypass grafting: a 6-month follow-up study. 151
Diagnostic accuracy and prognostic relevance of the measurement of the cardiac natriuretic peptides: a review 151
Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: compariosn with the old method and the Access system 151
Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay. 151
Evaluation of Analytical Performance of the Siemens ADVIA TnI Ultra Immunoassay 151
Association between 5,10-methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and conotruncal heart defects. 150
When gonads talk to the heart sex hormones and cardiac endocrine function. 150
B-type plasma natriuretic hormone level in operated Fallot patients 150
Analytical and clinical preformance of NT-proBNP immunoassay 150
Evaluation of reference change values for a hs-cTnI immunoassay using both plasma samples of healthy subjects and patients and quality control samples 150
Multicentre comparison of free thyroid hormones immunoassays: the Immunocheck study 149
A chromatographic method for the determination of uric acid turnover in man 149
Proposal for the use in emergency departments of cardiac troponins measured with the latest generation methods in patients with suspected acute coronary syndrome without persistent ST-segment elevation 149
Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients' survival 149
Totale 19.070
Salva come PNG Salva come JPEG
Categoria #
all - tutte 393.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 393.779
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.312 0 0 0 0 0 0 0 0 0 0 0 1.312
2020/202111.162 332 1.907 734 473 770 1.690 1.093 324 741 382 1.035 1.681
2021/20228.252 276 1.896 208 966 62 55 887 1.779 511 924 56 632
2022/20236.603 616 117 70 1.176 1.151 1.248 12 531 1.101 143 267 171
2023/20241.761 370 85 290 104 72 276 232 72 25 47 29 159
2024/202516.646 116 65 1.084 346 275 1.163 2.348 5.046 1.570 1.069 2.463 1.101
Totale 79.645